Hepatoportal Sclerosis-A Clinicopathologic Review of 28 Cases

Gastro Hep Adv. 2023 Jan 11;2(3):303-306. doi: 10.1016/j.gastha.2023.01.003. eCollection 2023.

Abstract

Background and aims: The aim of this study was to review a large series of cases with hepatoportal sclerosis (HPS) as a pathologically recognizable entity in liver tissue specimens and describe the associated clinical and radiographic manifestations, along with the outcomes of this entity.

Methods: Data were collected through a retrospective chart review.

Results: Twenty-eight patients were identified that had pathologically defined HPS. All patients had a significant past medical history and signs and symptoms of portal hypertension. The most consistent laboratory finding was an elevated alkaline phosphatase. Radiographically, 9 patients were mistakenly identified as having advanced fibrosis/cirrhosis. The initial histologic diagnosis was made on biopsy in 20 patients and after transplant in 8 patients. The severity of symptoms was variable and required transplantation in 11 patients, 3 were treated with transjugular intrahepatic portosystemic shunt, and the remaining patients were treated symptomatically.

Conclusion: HPS is associated with past medical history that may be causal in nature. Signs and symptoms may be severe enough to require liver transplantation. A significant proportion of patients are radiographically misdiagnosed as cirrhosis. In this small series, overall outcomes for transplanted patients are acceptable.

Keywords: Non-Cirrhotic Portal Hypertension; Portal Hypertension; Porto-Sinusoidal Vascular Disorder; Transplantation.